| Product NDC: | 45802-368 |
| Proprietary Name: | Imiquimod |
| Non Proprietary Name: | Imiquimod |
| Active Ingredient(s): | 12.5 mg/.25g & nbsp; Imiquimod |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 45802-368 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078837 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101109 |
| Package NDC: | 45802-368-53 |
| Package Description: | 12 PACKET in 1 CARTON (45802-368-53) > .25 g in 1 PACKET |
| NDC Code | 45802-368-53 |
| Proprietary Name | Imiquimod |
| Package Description | 12 PACKET in 1 CARTON (45802-368-53) > .25 g in 1 PACKET |
| Product NDC | 45802-368 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Imiquimod |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20101109 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | IMIQUIMOD |
| Strength Number | 12.5 |
| Strength Unit | mg/.25g |
| Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |